查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1736520

全球电子阿斯匹灵市场－按疼痛类型、最终用户、地区分類的市场规模，预测至 2025 年

Global Electronic Aspirin Market Size By Pain Type (Migraines, Cluster Headaches), By End-User (Hospitals, Clinics), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 | 商品交期: 2-3个工作天内

价格
简介目录

电子阿斯匹灵市场规模与预测

2024 年电子阿斯匹灵市场规模价值 46.7 亿美元，预计到 2032 年将达到 63.3 亿美元，预测期内（2026-2032 年）的复合年增长率为 5.89%。

推动市场成长的关键因素包括技术进步，以及患有持续性脸部头痛、丛集性头痛和偏头痛等疾病的人数不断增加。此外，生活方式的改变和工作压力也是导致这些疾病案例上升的其他因素，预计这些因素将在预测期内对市场成长产生积极贡献。全球电子阿斯匹灵市场报告对市场进行了全面的评估，对关键细分市场、趋势、市场驱动因素、竞争格局以及影响市场的关键因素进行了全面的分析。

全球电子阿斯匹灵市场定义

电子阿斯匹灵是由Automatic Technologies公司开发的医疗设备，有助于缓解偏头痛、头痛和紧张性头痛等症状引起的疼痛。电子阿斯匹灵是一种模拟神经的植入，连接到位于牙龈上方骨腔深处的翼腭神经节（SPG）。该装置透过微创手术植入，并由手持设备控制。该装置发出低强度的电子脉衝，刺激神经末梢并帮助阻断疼痛感受器。

预测期内，预计推动市场成长的主要因素包括：对偏头痛等症状的认知度不断提高、技术进步以及产品认证数量的增加。此外，全球神经系统疾病盛行率的上升以及政府措施不断增多，预计将进一步促进市场成长。

全球电子阿斯匹灵市场概况

偏头痛（一种通常导致大脑一侧搏动性或搏动性疼痛的头痛）的盛行率日益上升，是该装置的主要用途。偏头痛通常伴随呕吐、噁心以及对声音和光线的极度敏感。偏头痛的预防性治疗通常包括药物、注射、皮肤贴片和滴鼻剂，这些有助于在症状出现后控制症状。该疾病的高盛行率预计将支持市场的成长。例如，根据美国国家医学图书馆的报导，偏头痛是最常见的神经系统疾病之一，影响全球超过10亿人。这种疾病在年轻人和女性中更为常见。

此外，头痛和工作压力的增加预计将推动该设备的需求。根据世界卫生组织 (WHO) 的数据，成年人头痛的盛行率为 50%。此外，18 至 65 岁族群中，有一半至四分之三的人患有头痛。其中，30% 的人患有偏头痛。由于头痛是常见现象，大多数人会选择自行用药，包括服用众所周知的止痛药阿斯匹灵。

目录

第 1 章全球电子阿斯匹灵市场简介

  • 市场概览
  • 研究范围
  • 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

第四章全球电子阿斯匹灵市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

5. 全球电子阿斯匹灵市场（依疼痛类型）

  • 概述
  • 偏头痛
  • 丛集性头痛
  • 头痛/脸部疼痛

6. 全球电子阿斯匹灵市场（依最终用户）

  • 概述
  • 医院
  • 诊所
  • 门诊手术中心

7. 全球电子阿斯匹灵市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 阿拉伯聯合大公国
    • 沙乌地阿拉伯
    • 南非
    • 其他中东和非洲地区

8.全球电子阿斯匹灵市场的竞争格局

  • 概述
  • 各公司市场排名
  • 主要发展策略

第九章 公司简介

  • Autonomic Technologies, Inc.
    • 概述
    • 表现
    • 产品展望
    • 主要进展

第十章 重大进展

  • 产品发布/开发
  • 合併与收购
  • 业务扩展
  • 伙伴关係与合作

第十一章 附录

  • 相关调查
简介目录
Product Code: 37412

Electronic Aspirin Market Size And Forecast

Electronic Aspirin Market size was valued at USD 4.67 Billion in 2024 and is projected to reach USD 6.33 Billion by 2032, growing at a CAGR of 5.89% during the forecast period 2026-2032.

Major factors which drive the market growth include advances in technology, and a growing number of people suffering from conditions such as ongoing facial headaches, cluster headaches, and migraine. Moreover, changing lifestyles and work-related stress are some of the other factors that are increasing the instances of these conditions, which is expected to positively contribute to the growth of the market during the forecast period. The Global Electronic Aspirin Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Electronic Aspirin Market Definition

Electronic Aspirin is a medical device developed by Automatic Technologies that helps to alleviate pain from conditions such as migraines, headaches, and tension headaches. Electronic aspirin is a nerve-simulated implant that is connected to the Sphenopalatine Ganglion (SPG) which is a collection of nerves deep in the bone cavity of the upper gum. The device is implanted through a minimally invasive procedure and is controlled through a handheld device. The device sends low-level electronic impulses that stimulate the nerve endings that help to block the pain receptors.

Growing awareness about conditions such as migraines, technological advancement, and increasing product approvals are some of the key factors which are expected to contribute to the growth of the market during the forecast period. Moreover, the increasing prevalence of neurological conditions globally and increasing government initiatives in order to improve awareness are expected to further contribute to the growth of the market.

Global Electronic Aspirin Market Overview

The increasing prevalence of migraine a headache that causes pulsating sensation or throbbing pain usually on one side of the brain is a key condition for which the device is used. Migraine is usually accompanied by vomiting, nausea, and extreme sensitivity to sound and light. Preventive treatment for the condition usually involves drugs, injections, skin patches, and nasal sprays that help to stop the condition after its onset. The high prevalence of the condition is expected to support the growth of the market. For instance, according to an article by the National Library of Medicine, Migraine is one of the most common neurological disorders that affects more than 1 billion people globally. The condition is most common in young adults and females.

Moreover, increasing instances of headaches and work-related stress are expected to support the demand for the devices. According to the World Health Organization, the prevalence of headaches among adults was 50%. Moreover, half or three-quarters between the age of 18-65 suffer from headaches. Among this population, 30% of these individuals are reported to suffer from migraine. Due to headaches being a common phenomenon most people resort to self-medication which includes Aspirin which is a well-known analgesic.

Global Electronic Aspirin Market Segmentation Analysis

The Global Electronic Aspirin Market is segmented based on Pain Type, End-User, And Geography.

Electronic Aspirin Market, By Pain Type

  • Migraines
  • Cluster Headaches
  • Head and Facial Pain

Based on the Pain Type, The market is bifurcated into Migraines, Cluster Headaches, and Head and Facial Pain. The cluster headaches segment is expected to dominate during the forecast period owing to the higher prevalence of the condition among the population due to changing lifestyles and increasing work-related stress. For instance, according to an article by the American Institute of Stress, more than 40% of workers have reported job stress.

Electronic Aspirin Market, By End-User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Based on End-User, The market is bifurcated into Hospitals, Clinics, and Ambulatory Surgical Centers. The hospital segment held the largest share in 2022 due to the higher number of people undergoing treatment for conditions at the hospitals. Moreover, the availability of advanced infrastructure and favorable reimbursement policies are expected to support the growth of the segment during the forecast period.

Electronic Aspirin Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Based on Geography, The Global Electronic Aspirin Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest market in the global Electronic Aspirin Market this is attributed to the growing prevalence of neurological conditions, headaches, and migraines among the populations in the region. Moreover changing lifestyle and increasing work-related stress among young adults and adults is expected to positively impact the growth of the market.

Key Players

The "Global Electronic Aspirin Market" study report will provide valuable insight with an emphasis on the global market. Autonomic Technologies, Inc. Cefaly Technology, Omron Healthcare, TheraGun, Cochlear Limited, and Neurostim are the sole companies operating in the market.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Key Developments

  • In December 2022, Unity HA acquired the Intellectual Property of Autonomic Technologies. The acquisition will help Unity HA to continue with its new goal to continue advance cost-effective technologies in order to prevent and treat cluster headaches.
  • Ace Matrix Analysis
  • The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.
  • Market Attractiveness
  • The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Electronic Aspirin Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
  • Porter's Five Forces
  • The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Electronic Aspirin Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ELECTRONIC ASPIRIN MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL ELECTRONIC ASPIRIN MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL ELECTRONIC ASPIRIN MARKET, BY PAIN TYPE

  • 5.1 Overview
  • 5.2 Migraines
  • 5.3 Cluster Headaches
  • 5.4 Head and Facial Pain

6 GLOBAL ELECTRONIC ASPIRIN MARKET, BY END-USER

  • 6.1 Overview
  • 6.2 Hospitals
  • 6.3 Clinics
  • 6.4 Ambulatory Surgical Centers

7 7GLOBAL ELECTRONIC ASPIRIN MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 The U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 The U.K.
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Argentina
    • 7.5.3 Rest of LATAM
  • 7.6 Middle East and Africa
    • 7.6.1 UAE
    • 7.6.2 Saudi Arabia
    • 7.6.3 South Africa
    • 7.6.4 Rest of the Middle East and Africa

8 GLOBAL ELECTRONIC ASPIRIN MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILE

  • 9.1 Autonomic Technologies, Inc.
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments

10 KEY DEVELOPMENTS

  • 10.1 Product Launches/Developments
  • 10.2 Mergers and Acquisitions
  • 10.3 Business Expansions
  • 10.4 Partnerships and Collaborations

11 Appendix

  • 11.1 Related Research